NLSCX
Price
$18.19
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Net Assets
7.37B
VLSIX
Price
$17.74
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Net Assets
51.67M
Interact to see
Advertisement

NLSCX vs VLSIX

Header iconNLSCX vs VLSIX Comparison
Open Charts NLSCX vs VLSIXBanner chart's image
Neuberger Berman Long Short C
Price$18.19
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets7.37B
Virtus KAR Long/Short Equity I
Price$17.74
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets51.67M
NLSCX vs VLSIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NLSCX vs. VLSIX commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NLSCX is a Buy and VLSIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NLSCX has more cash in the bank: 7.37B vs. VLSIX (51.7M). VLSIX pays higher dividends than NLSCX: VLSIX (0.08) vs NLSCX (0.00). NLSCX was incepted earlier than VLSIX: NLSCX (13 years) vs VLSIX (7 years). NLSCX (2.43) is less costly to investors than VLSIX (2.19). NLSCX is a more actively managed with annual turnover of: 48.00 vs. VLSIX (31.00). NLSCX has a lower initial minimum investment than VLSIX: NLSCX (1000) vs VLSIX (100000). NLSCX annual gain was more profitable for investors over the last year : 7.00 vs. VLSIX (0.30). NLSCX (23.39) and VLSIX (22.95) have equivalent 5 years return.
NLSCXVLSIXNLSCX / VLSIX
Total Expense Ratio2.432.03120%
Annual Report Gross Expense Ratio2.432.19111%
Fund Existence13 years7 years-
Gain YTD2.8262.662106%
Front LoadN/AN/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets7.37B51.7M14,259%
Annual Yield % from dividends0.000.08-
Returns for 1 year7.000.302,311%
Returns for 3 years15.9319.4782%
Returns for 5 years23.3922.95102%
Returns for 10 years33.35N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBHCX14.42N/A
N/A
Neuberger Berman Equity Income C
APGYX113.65N/A
N/A
AB Large Cap Growth Advisor
ICTEX16.05N/A
N/A
ICON Health and Information Tech Instl
GIRMX25.68N/A
N/A
Goldman Sachs Emerging Markets Eq Inv
WGMVX4.09N/A
N/A
Wasatch Micro Cap Value Institutional